pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 24·1 min read
save

FDA unveils three psychedelic-focused commissioner vouchers

The FDA said Friday it has issued new fast-track vouchers to three psychedelic companies, and its selections have come as a “surprise” to Wall Street. In an unusual move, the agency didn’t name the sponsors ...

Apr 24, 2026·read at Endpoints ↗

April 24, 2026 01:26 PM EDTUpdated 11 hours ago R&DPharma Com­pass, Tran­scend and Usona In­sti­tute win FDA vouch­ers to ex­pe­dite new psy­che­delics Ayisha Sharma News Reporter The FDA said Fri­day it has is­sued new fast-track vouch­ers to three psy­che­del­ic com­pa­nies, and its se­lec­tions have come as a “sur­prise” to Wall Street. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
86 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 9h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 12h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 12h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 13h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 14h agoHealth tech investors are looking at bigger betsEndpoints